Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Diclofenac Dermal Products
NCT03145259Phase 1Completed
- Sponsor
- University of Maryland, Baltimore
- Start
- Apr 2017
- Primary completion
- Aug 2019
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of diclofenac in pain and inflammation, sponsored by University of Maryland, Baltimore. Started Apr 2017; status: completed.
02
Drugs
diclofenac
03
Conditions
paininflammation
Beyond the preview
Go deeper on NCT03145259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03145259.